Market Movers - OCT 3rd 2018
3 October 2018
RPM International Inc.
The stock price decreased by 3.1% reaching $62.00 in the pre-market session after the Company announced its Q1’18 reports, where it reported sales lower than expected.
Thomson Reuters Corporation
Share price increased by a 6.8% reaching $47.79 in the pre-market session with high volume after the Company announced preliminary results of buyback of approximately 138.7 million shares at a purchase price of $47 per share.
Alcoa Corporation Stock price went up by 6.2% reaching $44.15 in the premarket session after the announcement of Closing production by Alunorte, the world’s largest alumina factory due to an environmental dispute. Aluminium demand soared, elevating the price of Aluminium.
Tempur Sealy International, Inc.
TPX went up by an 8.8% reaching $52.62 in the pre-market session after Reuters disclosed that the Mattress Firm is planning to file for bankruptcy as soon as this week.
vTv Therapeutics Inc.
VTVT shares exploded by a 44% reaching $2.88 in the pre-market session after the Company recently reported an SEC 8-K filing which disclosed that top investor MacAndrews & Forbes Group, controlled by well-known investor Ronald Perelman, bought additional 1,879,699 Class A common shares at $1.33 per share pursuant to a July 30 agreement.
ELGX stocks escalated by a 36.6% reaching $2.35 in the pre-market session after the Company announced its Q3’18 Preliminary Sales of $34.3 million to $34.7 million.
Neovasc Inc. shares went up by a 32% reaching $2.97 in the pre-market session after the announcement that the surgery of the first U.S. patient implanted with a Neovasc Reducera was a successful surgery with a positive 12-week follow-up data and improvement in walking abilities and decreased pain.
The Stock price plunged by a 4.5% reaching $21.13 in the pre-market session as over the quarter, the Insider Sell to Insider Buy ratio remains around zero.
Kala Pharmaceuticals, Inc.
KALA went down by an 11.5% reaching $8.21 in the pre-market session announced that the Company has initiated an underwritten public offering of 7.50 million shares and also added that it closed its $110 million credit facility with funds managed by Athyrium Capital Management.
ADMA Biologics Inc
Share price went up by a 10.3% reaching $6.51 in the pre-market session after the Company announced that ADMA BioCenters which is its subsidiary firm has successfully got FDA approval for third plasma collection center.